68
52
Growth Score 68 in past quarter
-24 pts
Heat Score 52 in past quarter
-32 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
342203
Advent is a pharmaceutical company that develops, registers, and manufactures inhaled medicines.
- Annette Murphy: Project Leader
Anne Brindley: Chief Executive Officer
About the Company
Advent is an emerging pharmaceutical company established in Melbourne by a small team with experience and success in developing global respiratory products. Advent's near term goals are aimed at manufacture and global commercialization of our own pipeline with whom we have a highly credentialed international partner.
Advent's
entrepreneurial culture combines in-house design with leading providers to develop, register and manufacture a range of inhaled medicines. We are fast growing and need new people to enable us to expand and meet near and long term goals especially in upscaling manufacture capability.